Howard A. Cohen, MD, recognized as one of the pioneers in interventional cardiology in the United States and among the first cardiologists to perform angioplasty in this country, has been named Associate Director of the Cardiac Catheterization Laboratory and Director of the Structural Heart Intervention and Interventional Heart Failure Section at Lenox Hill Hospital.
Dr. Cohen, is well known nationally and internationally for his pioneering work with the TandemHeart, a new heart pump used to make cardiac catheterization possible for patients whose left ventricles are so damaged that angioplasty was previously not a possibility. With Dr. Cohen's appointment, Lenox Hill Hospital hopes to soon become the only hospital in New York City offering this new treatment.
Dr. Cohen comes to Lenox Hill Hospital from The University of Pittsburgh where he was Professor of Medicine and served as Director of Clinical Cardiology, Director of The Cardiac Catheterization Laboratory and Associate Director of Cardiovascular Institute. During his tenure as clinical leader of the program, the University of Pittsburgh Medical Center achieved national acclaim in U.S. News and World Report as one the leading Cardiology Programs in the country.
Dr. Cohen graduated cum laude from Yale College and earned his medical degree from the New York University School of Medicine in 1970. Following his training in Internal Medicine at Bellevue Hospital where he was an intern, resident and chief resident, he did his Cardiology Fellowship at the Johns Hopkins Hospital. He served two years at the National Naval Medical Center in Bethesda, Maryland and later became the Director of Interventional Cardiology and the Cardiac Catheterization Laboratories as well as Chief of Staff at Saint John's Hospital in California.
Dr. Cohen was the Founder and President of the Southern California Society of Interventional Cardiology. Collaborating with the cardiovascular surgeons, he was the first to report on "integrated coronary revascularization," a combination of coronary stenting with minimally invasive coronary artery bypass in patients with coronary anatomy that was difficult to treat. He is among the most experienced physicians in the area of radial artery access for both diagnostic and interventional procedures and has lectured extensively on this subject.
As a principal investigator for the National Heart, Lung and Blood Institute Dynamic Registry, Dr. Cohen has reported extensively on new devices and new approaches in interventional cardiology. Since its inception, he has been the program director for the Principles and Perspectives in Interventional Cardiology, the longest continuously running post-graduate course in the field.
Dr. Cohen has made numerous original contributions to the medical literature, and he serves as an editorial consultant for major peer review journals. He has also served on the medical advisory boards of multiple companies involved in the development of new devices in the field of interventional cardiology. His peers have repeatedly elected him to "The Best Doctors in America." Dr. Cohen is a fellow of the American College of Cardiology and the Society for Cardiac Angiography and Interventions.
He and his wife Christine live on the Upper East Side of Manhattan.
Members of the press seeking information about Lenox Hill Hospital should call the Public Relations Department at (212) 434-2400.